ArticleGene therapy2024

BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target.

Jing Qiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.